-transparent.png){kind=logo}
In addition to glucagon's role in regulating glucose production from the liver, a number of extrahepatic effects of glucagon have been reported. We have therefore examined various rat tissues for glucagon receptor mRNA expression. In liver, kidney, heart, adipose tissue, spleen, pancreatic islets, ovary, and thymus, glucagon receptor mRNA expression was found to be relatively abundant whereas lower levels were detected in stomach, small intestine, adrenal gland, thyroid, and skeletal muscle. The presence of glucagon receptor mRNA in tissues known to be responsive to glucagon suggests that these effects are mediated by specific glucagon receptors. Furthermore, the finding of glucagon receptor mRNA in the spleen, thymus, thyroid, adrenal gland, ovary, and skeletal muscle, where glucagon is not generally considered to act, indicates that there may be novel actions of glucagon that have yet to be determined.
L H Hansen, and
N Abrahamsen, and
E Nishimura
November 1994,
Molecular and cellular endocrinology,
L H Hansen, and
N Abrahamsen, and
E Nishimura
May 1995,
Regulatory peptides,
L H Hansen, and
N Abrahamsen, and
E Nishimura
July 1990,
FEBS letters,
L H Hansen, and
N Abrahamsen, and
E Nishimura
March 1996,
Neuroreport,
L H Hansen, and
N Abrahamsen, and
E Nishimura
October 1966,
Metabolism: clinical and experimental,
L H Hansen, and
N Abrahamsen, and
E Nishimura
February 1998,
Anatomy and embryology,
L H Hansen, and
N Abrahamsen, and
E Nishimura
November 1996,
Endocrinology,
L H Hansen, and
N Abrahamsen, and
E Nishimura
September 1998,
Molecular and cellular endocrinology,
L H Hansen, and
N Abrahamsen, and
E Nishimura
October 1997,
Journal of molecular neuroscience : MN,
L H Hansen, and
N Abrahamsen, and
E Nishimura
October 1998,
FEBS letters,
